Medicosurgical management of deep wound infections after thoracolumbar instrumentation: risk factors of poor outcomes.
Antibiotics
Drains
Spine surgery
Surgical site infection (SSI)
Thoracolumbar instrumentation
Journal
Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
10
12
2021
accepted:
18
01
2022
pubmed:
8
2
2022
medline:
28
4
2022
entrez:
7
2
2022
Statut:
ppublish
Résumé
Surgical site infection (SSI) after thoracolumbar osteosynthesis is a common complication. Its management relies on surgical revision and antibiotic therapy, but treatment failure is not uncommon. The aim of our study was to assess the frequency of SSI management failure and its risk factors. A retrospective study of patients hospitalized from 2011 to 2019 at the University Hospital of Caen was carried out. The infection rate and the time to onset of failure were assessed over a minimum follow-up of 1 year. Treatment failure was defined as the occurrence of a new intervention in the spine in the year following the end of antibiotic therapy, the establishment of long-term suppressive antibiotic therapy, or death from any cause within 1 year of the end of antibiotic therapy. We compared the treatment failure group with the treatment success group to determine risk factors for treatment failure. A total of 2881 patients underwent surgery during the study period, and 92 developed an SSI, corresponding to an SSI rate of 3.19%. Thirty-six percent of the patients with an SSI presented treatment failure. The median time to failure was 31 days. On multivariate analysis, diabetes mellitus was identified as a risk factor for treatment failure, whereas prolonged postoperative drainage for 4 to 5 days was a protective factor. The number of failures was significant, and failure occurred mainly during the early phase. To decrease the risk of treatment failure, prolonged duration of postoperative drainage seems to be helpful. Additionally, as diabetes is a risk factor for treatment failure, good control of glycemia in these patients might impact their outcomes.
Sections du résumé
BACKGROUND
Surgical site infection (SSI) after thoracolumbar osteosynthesis is a common complication. Its management relies on surgical revision and antibiotic therapy, but treatment failure is not uncommon. The aim of our study was to assess the frequency of SSI management failure and its risk factors.
METHODS
A retrospective study of patients hospitalized from 2011 to 2019 at the University Hospital of Caen was carried out. The infection rate and the time to onset of failure were assessed over a minimum follow-up of 1 year. Treatment failure was defined as the occurrence of a new intervention in the spine in the year following the end of antibiotic therapy, the establishment of long-term suppressive antibiotic therapy, or death from any cause within 1 year of the end of antibiotic therapy. We compared the treatment failure group with the treatment success group to determine risk factors for treatment failure.
RESULTS
A total of 2881 patients underwent surgery during the study period, and 92 developed an SSI, corresponding to an SSI rate of 3.19%. Thirty-six percent of the patients with an SSI presented treatment failure. The median time to failure was 31 days. On multivariate analysis, diabetes mellitus was identified as a risk factor for treatment failure, whereas prolonged postoperative drainage for 4 to 5 days was a protective factor.
CONCLUSIONS
The number of failures was significant, and failure occurred mainly during the early phase. To decrease the risk of treatment failure, prolonged duration of postoperative drainage seems to be helpful. Additionally, as diabetes is a risk factor for treatment failure, good control of glycemia in these patients might impact their outcomes.
Identifiants
pubmed: 35128604
doi: 10.1007/s00701-022-05128-7
pii: 10.1007/s00701-022-05128-7
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
881-890Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Références
Andrés-Cano P, Cerván A, Rodríguez-Solera M, Antonio Ortega J, Rebollo N, Guerado E (2018) Surgical infection after posterolateral lumbar spine arthrodesis: CT analysis of spinal fusion: SSI after posterolateral lumbar spine arthrodesis. Orthop Surg 10(2):89–97. https://doi.org/10.1111/os.12371
doi: 10.1111/os.12371
pubmed: 29770586
pmcid: 6594514
Barbanti-Brodano G, Griffoni C, Halme J et al (2020) Spinal surgery complications: an unsolved problem—is the World Health Organization Safety Surgical Checklist an useful tool to reduce them? Eur Spine J 29(5):927–936. https://doi.org/10.1007/s00586-019-06203-x
doi: 10.1007/s00586-019-06203-x
pubmed: 31696338
Barrey C, Launay O, Freitas E, Michel F, Laurent F, Chidiac C, Perrin G, Ferry T (2013) The follow-up of patients with postoperative infection of the spine. Eur J Orthop Surg Traumatol 23(S1):29–34. https://doi.org/10.1007/s00590-013-1243-9
doi: 10.1007/s00590-013-1243-9
Benito N, Mur I, Ribera A et al (2019) The different microbial etiology of prosthetic joint infections according to route of acquisition and time after prosthesis implantation, including the role of multidrug-resistant organisms. J Clin Med 8(5):673. https://doi.org/10.3390/jcm8050673
doi: 10.3390/jcm8050673
pmcid: 6572185
Betz M, Uçkay I, Schüpbach R, Gröber T, Botter SM, Burkhard J, Holy D, Achermann Y, Farshad M (2020) Short postsurgical antibiotic therapy for spinal infections: protocol of prospective, randomized, unblinded, noninferiority trials (SASI trials). Trials 21(1):144. https://doi.org/10.1186/s13063-020-4047-3
doi: 10.1186/s13063-020-4047-3
pubmed: 32028985
pmcid: 7006138
Carl HM, Ahmed AK, Abu-Bonsrah N et al (2018) Risk factors for wound-related reoperations in patients with metastatic spine tumor. J Neurosurg Spine 28(6):663–668. https://doi.org/10.3171/2017.10.SPINE1765
doi: 10.3171/2017.10.SPINE1765
pubmed: 29547061
Chen S-H, Lee C-H, Huang K-C, Hsieh P-H, Tsai S-Y (2015) Postoperative wound infection after posterior spinal instrumentation: analysis of long-term treatment outcomes. Eur Spine J 24(3):561–570. https://doi.org/10.1007/s00586-014-3636-9
doi: 10.1007/s00586-014-3636-9
pubmed: 25351841
Deng H, Chan AK, Ammanuel SG et al (2020) Risk factors for deep surgical site infection following thoracolumbar spinal surgery. J Neurosurg Spine 32(2):292–301. https://doi.org/10.3171/2019.8.SPINE19479
doi: 10.3171/2019.8.SPINE19479
Dubee V, Lenoir T, Leflon-Guibout V, Briere-Bellier C, Guigui P, Fantin B (2012) Three-month antibiotic therapy for early-onset postoperative spinal implant infections. Clin Infect Dis 55(11):1481–1487. https://doi.org/10.1093/cid/cis769
doi: 10.1093/cid/cis769
pubmed: 22942207
European Spine Study Group, Haddad S, Núñez-Pereira S et al (2018) The impact of deep surgical site infection on surgical outcomes after posterior adult spinal deformity surgery: a matched control study. Eur Spine J 27(10):2518–2528. https://doi.org/10.1007/s00586-018-5583-3
doi: 10.1007/s00586-018-5583-3
Hegde V, Meredith DS, Kepler CK, Huang RC (2018) Management of postoperative spinal infections. World J Orthop 3(11):182–189. https://doi.org/10.5312/wjo.v3.i11.182
doi: 10.5312/wjo.v3.i11.182
de la Hera B, Sánchez-Mariscal F, Gómez-Rice A, Vázquez-Vecilla I, Zúñiga L, Ruano-Soriano E (2021) Deep surgical-site infection following thoracolumbar instrumented spinal surgery: the experience of 25 years. Int J Spine Surg 15(1):144–152. https://doi.org/10.14444/8019
doi: 10.14444/8019
pubmed: 33900968
pmcid: 7931697
Janssen DMC, van Kuijk SMJ, d’Aumerie B, Willems P (2019) A prediction model of surgical site infection after instrumented thoracolumbar spine surgery in adults. Eur Spine J 28(4):775–782. https://doi.org/10.1007/s00586-018-05877-z
doi: 10.1007/s00586-018-05877-z
pubmed: 30617836
Kim JI, Suh KT, Kim S-J, Lee JS (2010) Implant removal for the management of infection after instrumented spinal fusion. J Spinal Disord Tech 23(4):258–265. https://doi.org/10.1097/BSD.0b013e3181a9452c
doi: 10.1097/BSD.0b013e3181a9452c
pubmed: 20084022
de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB (2009) Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 37(5):387–397. https://doi.org/10.1016/j.ajic.2008.12.010
doi: 10.1016/j.ajic.2008.12.010
pubmed: 19398246
Manet R, Ferry T, Castelain J-E, Bracho GP, Freitas-Olim E, Grando J, Barrey C (2018) Relevance of modified debridement-irrigation, antibiotic therapy and implant retention protocol for the management of surgical site infections: a series of 1694 instrumented spinal surgery. J Bone Jt Infect 3(5):266–272. https://doi.org/10.7150/jbji.28765
doi: 10.7150/jbji.28765
pubmed: 30662819
pmcid: 6328300
Mok JM, Guillaume TJ, Talu U, Berven SH, Deviren V, Kroeber M, Bradford DS, Hu SS (2009) Clinical outcome of deep wound infection after instrumented posterior spinal fusion: a matched cohort analysis. Spine 34(6):578–583. https://doi.org/10.1097/BRS.0b013e31819a827c
doi: 10.1097/BRS.0b013e31819a827c
pubmed: 19240667
Ogihara S, Yamazaki T, Shiibashi M et al (2020) Risk factor analysis of deep surgical site infection after posterior instrumented fusion surgery for spinal trauma: a multicenter observational study. World Neurosurg 134:e524–e529. https://doi.org/10.1016/j.wneu.2019.10.117
doi: 10.1016/j.wneu.2019.10.117
pubmed: 31669691
On behalf of the Scoliosis Research Society (SRS), Pesenti S, Pannu T et al (2018) What are the risk factors for surgical site infection after spinal fusion? A meta-analysis. Eur Spine J 27(10):2469–2480. https://doi.org/10.1007/s00586-018-5733-7
doi: 10.1007/s00586-018-5733-7
Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR (2013) Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of Americaa. Clin Infect Dis 56(1):e1–e25. https://doi.org/10.1093/cid/cis803
doi: 10.1093/cid/cis803
Quraishi NA, Ahmed MS, Arealis G, Boszczyk BM, Edwards KL (2019) Does surgical site infection influence neurological outcome and survival in patients undergoing surgery for metastatic spinal cord compression? Eur Spine J 28(4):792–797. https://doi.org/10.1007/s00586-018-5797-4
doi: 10.1007/s00586-018-5797-4
pubmed: 30368596
Schwarz EM, Parvizi J, Gehrke T et al (2019) 2018 International Consensus Meeting on Musculoskeletal Infection: Research Priorities from the General Assembly Questions. J Orthop Res 37(5):997–1006. https://doi.org/10.1002/jor.24293
doi: 10.1002/jor.24293
pubmed: 30977537
Wille H, Dauchy F-A, Desclaux A, Dutronc H, Vareil M-O, Dubois V, Vital J-M, Dupon M (2017) Efficacy of debridement, antibiotic therapy and implant retention within three months during postoperative instrumented spine infections. Infect Dis 49(4):261–267. https://doi.org/10.1080/23744235.2016.1255351
doi: 10.1080/23744235.2016.1255351
Zhou J, Wang R, Huo X, Xiong W, Kang L, Xue Y (2020) Incidence of surgical site infection after spine surgery: a systematic review and meta-analysis. Spine 45(3):208–216. https://doi.org/10.1097/BRS.0000000000003218
doi: 10.1097/BRS.0000000000003218
pubmed: 31464972
Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, Keohane C, Denham CR, Bates DW (2013) Health care–associated infections: a meta-analysis of costs and financial impact on the US Health Care System. JAMA Intern Med 173(22):2039. https://doi.org/10.1001/jamainternmed.2013.9763
doi: 10.1001/jamainternmed.2013.9763
pubmed: 23999949